Dr. Laleh Talebian
Dr. Laleh Talebian, a former clinical research scientist who is now the founder and CEO of Dynamic Natural Advantage (DNA), is leading a revolution in chronic disease care. She has developed a methodology that challenges the pharmaceutical default and positions food as a therapeutic tool grounded in molecular science.
Dr. Laleh’s early life was shaped by survival and domestic challenges. Born in Iran despite her mother’s attempts to terminate the pregnancy, she found guidance and strength in her father, who instilled the values of education and fearlessness before passing away from cancer. Despite being told that a scientific career was unattainable for a woman and enduring a difficult relationship, her determination led her to earn a Bachelor’s in genetics and a Ph.D. in molecular biology.
After years in clinical trials and peer-reviewed research, Dr. Laleh experienced a shift in focus, moving from reactive treatment to preventative health. “I was a trained research scientist conducting clinical trials. But I learned that drugs are harming people more than healing them. That realization changed the course of my career,” she explains.
Transitioning to nutritional and functional healing, she now promotes the philosophy that most chronic diseases can be managed or prevented through lifestyle and diet. Her departure from traditional academic medicine was followed by repeated attempts to integrate nutritional therapeutics into research settings, where she encountered resistance and funding challenges.
In 2010, she began developing her own framework while working full-time as a clinical research scientist. She quickly found interest after delivering a talk at a local gym. “I had clients signing up immediately,” she recalls, demonstrating demand beyond oncology, her initial focus. In 2018, she left academia to lead DNA full-time. “It was scary at first. I was not a businesswoman, I was a scientist. But it was the best decision I’ve ever made. I never looked back,” she says.
Dr. Laleh’s methodology, known as the Precision Empowerment Pathway, applies the logic of targeted pharmaceutical therapy while replacing synthetic compounds with nutritional interventions. “In oncology, clinicians often target specific genetic mutations with precision pharmaceuticals. I apply that same analytical approach to food and botanical compounds,” she explains. She curates personalized plans using food to address specific medical conditions.
“I examine disease markers, genetic attributes, and epigenetic factors, then target those pathways with food, herbs, and natural remedies, often in combination with synthetic drugs,” she adds.
Dr. Laleh Talebian
Her approach also emphasizes standardization. Drawing from her medical experience, she notes that clinical trials group patients by diagnosis and apply uniform treatment protocols. “In my practice, every single person receives a unique plan. Not one protocol is the same,” she says.
Nineteen percent of adults in the United States use natural products, including functional foods and animal-based products for health purposes, highlighting demand for alternatives. Dr. Laleh believes this need is driven by the fact that an estimated 194 million Americans have at least one major chronic disease, such as heart disease, stroke, cancer, or diabetes.
She maintains that many of these conditions are not inevitable. “In my view, about 85 percent of chronic conditions, including cancer, are preventable or manageable with diet, mindset, and movement,” she says.
Her client process begins with data analysis. She reviews existing lab work, identifies gaps, and often funds additional testing herself to bypass insurance limitations. Multigenerational health histories provide insight into inherited risk patterns. Epigenetic factors like stress, sleep, and environmental toxins receive equal attention. She also collects detailed dietary logs to understand behavior.
From there, she designs a phased protocol lasting nine to twelve months. Each client receives a customized supplement formulation in a single bottle, tested for safety against their medications. “People can order anything online. A supplement that is beneficial for one person can be harmful to another if it interacts with their medication,” she notes.
A structured home detox is another key component. Clients eliminate environmental toxins from kitchens and living spaces and replace them with non-toxic alternatives. Dr. Laleh also customizes nutritional plans based on geography as well as biology. “A client in rural France receives a different sourcing guide than one in California. Every recommended food comes with an explanation linking it to specific biomarkers or therapeutic goals,” she explains.
She observes that trust in healthcare institutions has fluctuated, especially after the pandemic increased scrutiny of medical guidance. Patients are now seeking practitioners who educate them. “I translate medical jargon into language people can understand. They deserve to know what is happening in their bodies so they can make informed decisions,” she says.
Accessibility and accountability are central to her approach, as she remains available daily through text or email. Virtual consultations enable her to work with clients across North America and Europe.
Ultimately, DNA treats nutrition as a biologically targeted intervention that rejects wellness fads and lifestyle trends. Dr. Laleh Talebian offers a grounded scientific reassessment that insists precision should apply not only to pharmaceuticals but also to what is on our plate. “Food is something we engage with every day. Why not use it intentionally?” she asks
